title: Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.
authors: Renal Research Labs, Manchester Royal Infirmary and Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom paul.brenchley@manchester.ac.uk.
authors: Paul E C
authors: PE
authors: Brenchley
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D054507:Receptors, Phospholipase A2 / Q000276:immunology*; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D001323:Autoantibodies; D007155:Immunologic Factors; D054507:Receptors, Phospholipase A2; D000069283:Rituximab
keywords: anti-PLA2R; immunosuppression; membranous nephropathy; rituximab